4.5 Review Book Chapter

Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism

Journal

ANNUAL REVIEW OF PHYSIOLOGY, VOL 75
Volume 75, Issue -, Pages 503-533

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-physiol-030212-183727

Keywords

calcium; phosphate; FGF23; Klotho; kidney; bone

Categories

Funding

  1. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092461, R01DK091392] Funding Source: NIH RePORTER
  2. NIDDK NIH HHS [R01 DK091392, R01 DK092461] Funding Source: Medline

Ask authors/readers for more resources

The metabolically active and perpetually remodeling calcium phosphate-based endoskeleton in terrestrial vertebrates sets the demands on whole-organism calcium and phosphate homeostasis that involves multiple organs in terms of mineral flux and endocrine cross talk. The fibroblast growth factor (FGF)-Klotho endocrine networks epitomize the complexity of systems biology, and specifically, the FGF23-alpha Klotho axis highlights the concept of the skeleton holding the master switch of homeostasis rather than a passive target organ as hitherto conceived. Other than serving as a coreceptor for FGF23, alpha Klotho circulates as an endocrine substance with a multitude of effects. This review covers recent data on the physiological regulation and function of the complex FGF23-alpha Klotho network. Chronic kidney disease is a common pathophysiological state in which FGF23-alpha Klotho, a multiorgan endocrine network, is deranged in a self-amplifying vortex resulting in organ dysfunction of the utmost severity that contributes to its morbidity and mortality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available